6505--Bumetanide Tablets (VA-26-00011200)
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0068
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Andrew Cazares andrew.cazares@va.gov (708) 786-4990
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is procuring Bumetanide Tablets through an unrestricted Request for Proposal (RFP 36E79725R0068) to serve multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Offerors must provide an exact drug name matching the product label, possess a unique NDC number assigned to their organization, and commit to providing an uninterrupted source of supply throughout the contract period. The solicitation will be issued in commercial item format in accordance with FAR Part 12 on or about October 30, 2025, with a response deadline of November 13, 2025 at 2:30 PM Central Time. The VA will award a single contract to the responsible offeror deemed most advantageous to the government, though specific evaluation criteria are not detailed in the presolicitation notice. Interested vendors should monitor SAM.gov continuously for solicitation updates and direct technical questions to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov.
This procurement carries no set-aside designation and represents an unrestricted competition open to all responsible sources. The contract will run for one base year with four pre-priced one-year option periods, with products distributed through the VA and DoD Pharmaceutical Prime Vendor Programs. Estimated annual requirements span five different Bumetanide tablet strengths (0.5mg, 1mg, and 2mg) in both 100 and 500 tablet package sizes, with annual usage estimates ranging from approximately 11,493 to 31,067 bottles depending on the specific strength and package configuration. The presolicitation notice does not identify current contractors or provide specific award value information. All procurement documentation will be available electronically through SAM.gov, with no paper copies distributed.
Notice text
PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0068 for an unrestricted procurement for Bumetanide Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).Â
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.Â
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.
Solicitation # 36E79725R0068 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 30, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Andrew J. Cazares. Questions can be e-mailed to Andrew.Cazares@va.gov. Â
The estimated annual requirements are as follows:Â
Â
Â
REQUIREMENT DESCRIPTIONÂ
ITEMÂ
DESCRIPTIONÂ
PACKAGE SIZE (Tablets per Bottle)Â
TOTAL ESTIMATED ANNUAL USAGE (Bottles)Â
1Â
Bumetanide 0.5mg Tablet
100Â
16,351Â
2Â
Bumetanide 1mg Tablet
100Â
31,067Â
3
Bumetanide 1mg Tablet
500
13,324
4
Bumetanide 2mg Tablet
100
20,529
5
Bumetanide 2mg Tablet
500
11,493
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79725R0068_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Bumetanide Tablets | Award Notice | |
| 6505--Bumetanide Tablets (VA-26-00011200) | Solicitation | |
| 6505--Bumetanide Tablets (VA-26-00011200) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity